Chloramphenicol: new perspectives on an old drug

Insights

Chloramphenicol use is rising for childhood infections. New pharmacokinetic data highlight variable bioavailability and clearance, necessitating careful dosing based on age and serum levels to avoid toxicity.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Pediatrics

Background:

  • Chloramphenicol is experiencing a resurgence in treating serious childhood infections, particularly those caused by ampicillin-resistant Hemophilus influenzae type b.
  • Increased clinical use and advanced analytical methods have spurred recent investigations into chloramphenicol and its prodrug esters.

Purpose of the Study:

  • To review current pharmacokinetic data on chloramphenicol and its prodrugs, chloramphenicol succinate and chloramphenicol palmitate.
  • To emphasize the clinical implications of these pharmacokinetic findings in light of chloramphenicol's toxicity profile.

Main Methods:

  • Review of recent literature on chloramphenicol pharmacokinetics.
  • Analysis of bioavailability data for chloramphenicol succinate and chloramphenicol palmitate.
  • Examination of interpatient variability in chloramphenicol clearance.

Main Results:

  • Incomplete bioavailability of chloramphenicol succinate was observed.
  • Chloramphenicol palmitate may offer superior bioavailability compared to chloramphenicol succinate.
  • Significant interpatient variability in chloramphenicol clearance was documented.

Conclusions:

  • Pharmacokinetic variability necessitates individualized chloramphenicol dosing.
  • Age-based initial dosing and therapeutic drug monitoring of peak serum concentrations are crucial.
  • Careful patient monitoring is essential due to the risk of serious hematologic and metabolic toxicities.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...